Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)

Madappa N. Kundranda, Antonio Cubillo Gracián, Syed F. Zafar, E. Meiri, Johanna C. Bendell, Hana Algül, Fernando Rivera, Eugene R. Ahn, David Watkins, Uwe Pelzer,

Annals of Oncology · 2020 · 52 citations · 21 references

DOIFull text

Open access

Concepts

References

21